Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ImevaX GmbH
DescriptionProphylactic H. pylori vaccine comprising the adjuvant in IMX101 and a fused protein containing components of the IMX101 antigens
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHelicobacter
Indication DetailsVaccinate against Helicobacter pylori (H. pylori) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today